Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
48
IMRX Quote, Financials, Valuation and Earnings
Last price:
$2.00
Seasonality move
:
-14.17%
Day range:
$1.79 - $2.08
52-week range:
$1.00 - $7.92
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
186.84x
P/B ratio:
1.08x
Volume:
678.7K
Avg. volume:
708K
1-year change:
-70.07%
Market cap:
$62.3M
Revenue:
--
EPS (TTM):
-$1.97
Earnings Data
Next earnings date for IMRX
Feb 28
2025
Most recent earnings per share
-$0.49
Beat by $0.06
(Nov 13/2024)
Consensus Estimate
-$0.55
(Nov 13/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
IMRX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/28/2025 | Q4 | -- | -- | -- | -$0.39 | -- |
| 11/13/2024 | Q3 | -- | -- | -$0.49 | -$0.55 | $0.06 |
| 08/06/2024 | Q2 | -- | -- | -$0.47 | -$0.53 | $0.06 |
| 05/07/2024 | Q1 | -- | -- | -$0.49 | -$0.50 | $0.01 |
| 03/01/2024 | Q4 | -- | -- | -$0.52 | -$0.48 | -$0.04 |
| 11/09/2023 | Q3 | -- | -- | -$0.43 | -$0.49 | $0.06 |
| 08/03/2023 | Q2 | -- | -- | -$0.43 | -$0.53 | $0.10 |
| 05/04/2023 | Q1 | -- | -- | -$0.51 | -$0.56 | $0.05 |
| 03/06/2023 | Q4 | -- | -- | -$0.50 | -$0.56 | $0.06 |
| 11/10/2022 | Q3 | -- | -- | -$0.49 | -$0.48 | -$0.01 |
| 08/10/2022 | Q2 | -- | -- | -$0.44 | -- | -- |
| 05/10/2022 | Q1 | -- | -- | -$0.49 | -- | -- |
| 03/10/2022 | Q4 | -- | -- | -$0.42 | -- | -- |
| 11/09/2021 | Q3 | -- | -- | -$0.47 | -- | -- |
| 09/09/2021 | Q2 | -- | -- | -$0.33 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.46 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.43 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.33 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.27 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.24 | -- | -- |
Immuneering Earnings Questions
-
How Much did Immuneering Generate in Revenue Last Quarter?
Immuneering reported -- worth of top line sales in its most recent quarter.
-
Did Immuneering Beat Earnings Last Quarter?
Immuneering announced earnings per share of -$0.49 which represents a beat of analyst forecast a -$0.55 per share.
-
Is Immuneering Profitable?
Immuneering reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Immuneering EPS Next Year?
Immuneering's earnings are forecast to decrease from -$1.88 per share to -$1.85 per share next year representing a decrease of -4.61%.
-
When is Immuneering's Earnings Date?
Immuneering's next earnings date is February 28, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
